Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avidity Biosciences, Inc.

30.32
-0.3000-0.98%
Volume:56.47K
Turnover:1.71M
Market Cap:3.65B
PE:-10.01
High:30.64
Open:30.14
Low:30.00
Close:30.62
Loading ...

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
21 Jan

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PR Newswire
·
21 Jan

Bank of America Securities Remains a Buy on Avidity Biosciences (RNA)

TIPRANKS
·
15 Jan

Avidity Biosciences: Strategic Advancements in Key Programs Drive Buy Rating

TIPRANKS
·
15 Jan

Wave Life Sciences: Buy Rating Based on Promising Clinical Updates and RNA Editing Advancements

TIPRANKS
·
14 Jan

Is Wave Life Sciences (WVE) the Top Small Cap Stock to Buy with the Highest Upside Potential?

Insider Monkey
·
14 Jan

Wave Life Sciences Advances in RNA Editing Innovations

TIPRANKS
·
14 Jan

Sarepta Announces Q4 2024 Revenue Of $638.2M, Exceeding Guidance; ELEVIDYS Revenue At $384.2M; RNA PMO Revenue At $254M; FY24 Revenue Totals $1.79B; $1.5B In Cash And Investments At Year-End 2024; Reiterates 2025 Revenue Guidance Of $2.9B-$3.1B

Benzinga
·
14 Jan

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

ACCESSWIRE
·
13 Jan

Korro Bio Announces Dosing of First Participants in REWRITE Phase 1/2a Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency and Provides Pipeline Update

GlobeNewswire
·
13 Jan

Analysts Offer Insights on Healthcare Companies: Avidity Biosciences (RNA), Celldex (CLDX) and Centessa Pharmaceuticals (CNTA)

TIPRANKS
·
13 Jan

ProQR’s Strategic Focus on RNA Editing for Liver Disease: Targeting PNPLA3 in the MASH Space

TIPRANKS
·
13 Jan

Avidity Biosciences Price Target Maintained With a $72.00/Share by HC Wainwright & Co.

Dow Jones
·
10 Jan

Circio Holding ASA Registers Share Capital Increase to Boost RNA Therapeutics and Cancer Vaccine Research

TIPRANKS
·
09 Jan

Analysts Offer Insights on Healthcare Companies: NeuroPace (NPCE), Tecan Group AG (OtherTCHBF) and Avidity Biosciences (RNA)

TIPRANKS
·
09 Jan

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
09 Jan

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PR Newswire
·
09 Jan

Tempus, Genialis Collaborate to Advance RNA-Based Biomarker Algorithms for Cancer Treatment

MT Newswires Live
·
09 Jan

Avidity Biosciences Plans to Submit First Biologics License Application This Year

MT Newswires Live
·
09 Jan

BRIEF-Avidity Biosciences Confirms Accelerated Approval Path for Del-Zota with BLA Planned For Year End 2025

Reuters
·
08 Jan